{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:55:46Z","timestamp":1794930946785,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2504"],"award-info":[{"award-number":["GRK2504"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA1289\/7-3"],"award-info":[{"award-number":["MA1289\/7-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TS87\/16-3"],"award-info":[{"award-number":["TS87\/16-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["WSS MA\/TS 2018.121.1"],"award-info":[{"award-number":["WSS MA\/TS 2018.121.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.antiviral.2020.104788","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:32:48Z","timestamp":1585909968000},"page":"104788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice"],"prefix":"10.1016","volume":"178","author":[{"given":"Markus","family":"Wild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca D.","family":"Bertzbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tannig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana B.","family":"Tsogoeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt B.","family":"Kaufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104788_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","article-title":"Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods","volume":"86","author":"Aickin","year":"1996","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.antiviral.2020.104788_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jviromet.2011.03.005","article-title":"A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate","volume":"173","author":"Auerochs","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2020.104788_bib3","doi-asserted-by":"crossref","first-page":"104606","DOI":"10.1016\/j.antiviral.2019.104606","article-title":"Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus","volume":"171","author":"Bertzbach","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104788_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7120588","article-title":"Marek's disease virus infection of natural killer cells","volume":"7","author":"Bertzbach","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.antiviral.2020.104788_bib5","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.bmc.2018.05.041","article-title":"Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin","volume":"26","author":"Capci Karagoz","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104788_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00658-19","article-title":"A common live-attenuated avian herpesvirus vaccine expresses a very potent oncogene","volume":"4","author":"Conradie","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.antiviral.2020.104788_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104788_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104788_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-0012.2007.00761.x","article-title":"Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes","volume":"22","author":"Eid","year":"2008","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.antiviral.2020.104788_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation \u2013 challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.antiviral.2020.104788_bib11","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action","volume":"24","author":"Fr\u00f6hlich","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.antiviral.2020.104788_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin-estrogen hybrids highly active against HCMV, P. Falciparum, and cervical and breast cancer","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104788_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acsmedchemlett.7b00412","article-title":"Synthesis of thymoquinone-artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104788_bib14","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/infdis\/jiw217","article-title":"Cytomegalovirus and HIV: a dangerous pas de Deux","volume":"214","author":"Gianella","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104788_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.02.013","article-title":"Artesunate-derived monomeric, dimeric and trimeric experimental drugs - their unique mechanistic basis and pronounced antiherpesviral activity","volume":"152","author":"Hahn","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104788_bib16","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2020.104788_bib17","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/ncomms15071","article-title":"Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions","volume":"8","author":"Held","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104788_bib18","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand. J. Stat."},{"key":"10.1016\/j.antiviral.2020.104788_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2015.10.003","article-title":"The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-kappaB) pathway by targeting RelA\/p65","volume":"124","author":"Hutterer","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104788_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0923-1811(99)00085-7","article-title":"Current understanding of cytomegalovirus infection in immunocompetent individuals","volume":"22","author":"Kano","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.antiviral.2020.104788_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bmc.2018.11.018","article-title":"Synthesis of new betulinic acid\/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities","volume":"27","author":"Karagoz","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104788_bib22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/infdis\/148.3.406","article-title":"Lethal infection with murine cytomegalovirus after early viral replication in the spleen","volume":"148","author":"Katzenstein","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104788_bib23","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2007-06-095414","article-title":"Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells","volume":"110","author":"Klenovsek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2020.104788_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5694\/mja14.00183","article-title":"Cytomegalovirus disease in immunocompetent adults","volume":"201","author":"Lancini","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.antiviral.2020.104788_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2105\/AJPH.86.5.628","article-title":"On the Holm, Simes, and Hochberg multiple test procedures","volume":"86","author":"Levin","year":"1996","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.antiviral.2020.104788_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/338143","article-title":"High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy","volume":"185","author":"Limaye","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104788_bib27","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104788_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.antiviral.2013.10.003","article-title":"Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis","volume":"100","author":"Marschall","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104788_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104788_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2009.05.017","article-title":"Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate","volume":"46","author":"Milbradt","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104788_bib31","first-page":"12","article-title":"Recent developments in herpesvirus therapy","volume":"8","author":"Naesens","year":"2001","journal-title":"Herpesviridae"},{"key":"10.1016\/j.antiviral.2020.104788_bib32","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104788_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104788_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/jinf.2001.0949","article-title":"Clinical aspects and management of cytomegalovirus infection","volume":"44","author":"Sissons","year":"2002","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2020.104788_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.11.008","article-title":"In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model","volume":"161","author":"Sonntag","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104788_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2016.01.022","article-title":"MCMV exploits the spleen as a transfer hub for systemic dissemination upon oronasal inoculation","volume":"217","author":"Zhang","year":"2016","journal-title":"Virus Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:03Z","timestamp":1759062723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"alternative-id":["S0166354220302023"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104788","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104788"}}